Insider · CIK 0001666963

Kung Winston

Reports to the SEC for 5 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001666963

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15.5K sh	—	—	15,500
2026-06-11	JANXJanux Therapeutics, Inc.A Award	Director	AAward	+5,500 sh	—	—	11,750
2026-06-10	CRBPCorbus Pharmaceuticals Holdings, Inc.S Sale	Director	SSale	−2,026 sh	$7.91	−$16K	12,140
2026-05-19	CRBPCorbus Pharmaceuticals Holdings, Inc.A Award	Director	AAward	+3,800 sh	—	—	14,166
2026-05-19	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock options (right to buy)A Award	Director	AAward	+12.3K sh	—	—	12,300
2026-02-02	AVBPArriVent BioPharma, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+140K sh	—	—	140,000
2025-06-11	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.7K sh	—	—	11,667
2025-06-11	JANXJanux Therapeutics, Inc.A Award	Director	AAward	+3,750 sh	—	—	6,250
2025-05-30	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock options (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2025-05-30	CRBPCorbus Pharmaceuticals Holdings, Inc.A Award	Director	AAward	+4,800 sh	—	—	10,366
2025-02-03	AVBPArriVent BioPharma, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+120K sh	—	—	120,000
2024-08-16	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock options (right to buy)A Award	Director	AAward	+5,566 sh	—	—	5,566
2024-08-16	CRBPCorbus Pharmaceuticals Holdings, Inc.A Award	Director	AAward	+5,566 sh	—	—	5,566
2024-06-26	JANXJanux Therapeutics, Inc.A Award	Director	AAward	+2,500 sh	—	—	2,500
2024-06-26	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,350 sh	—	—	8,350
2023-06-14	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2023-05-12	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	COO, CFO	AAward	+150K sh	—	—	150,000
2022-11-25	PMVPPMV Pharmaceuticals, Inc.G Gift	COO, CFO	GGift	−2,560 sh	—	—	10,600
2022-09-21	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,375 sh	—	—	9,375
2022-09-21	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2022-04-20	PMVPPMV Pharmaceuticals, Inc.M Exercise/Conversion	COO, CFO	MExercise/Conversion	+4,000 sh	$3.22	+$12.9K	10,600
2022-04-20	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	COO, CFO	MExercise/Conversion	−4,000 sh	—	—	210,034
2022-02-10	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	COO, CFO	AAward	+104K sh	—	—	104,400
2021-12-30	PMVPPMV Pharmaceuticals, Inc.G Gift	COO, CFO	GGift	−2,725 sh	—	—	6,600
2021-08-19	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	COO, CFO	MExercise/Conversion	−5,000 sh	—	—	214,034
2021-08-19	PMVPPMV Pharmaceuticals, Inc.M Exercise/Conversion	COO, CFO	MExercise/Conversion	+5,000 sh	$3.22	+$16.1K	6,600
2021-08-03	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	COO, CFO	MExercise/Conversion	−4,500 sh	—	—	219,034
2021-08-03	PMVPPMV Pharmaceuticals, Inc.M Exercise/Conversion	COO, CFO	MExercise/Conversion	+4,500 sh	$3.22	+$14.5K	6,100
2021-08-03	PMVPPMV Pharmaceuticals, Inc.S Sale	COO, CFO	SSale	−4,500 sh	$33.82	−$152K	1,600
2021-07-08	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	COO, CFO	MExercise/Conversion	−4,500 sh	—	—	223,534
2021-07-08	PMVPPMV Pharmaceuticals, Inc.S Sale	COO, CFO	SSale	−4,500 sh	$33.75	−$152K	1,600
2021-07-08	PMVPPMV Pharmaceuticals, Inc.M Exercise/Conversion	COO, CFO	MExercise/Conversion	+4,500 sh	$3.22	+$14.5K	6,100
2021-06-04	PMVPPMV Pharmaceuticals, Inc.S Sale	COO, CFO	SSale	−4,500 sh	$33.75	−$152K	1,600
2021-06-04	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	COO, CFO	MExercise/Conversion	−4,500 sh	—	—	228,034
2021-06-04	PMVPPMV Pharmaceuticals, Inc.M Exercise/Conversion	COO, CFO	MExercise/Conversion	+4,500 sh	$3.22	+$14.5K	6,100
2021-05-12	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	COO, CFO	AAward	+50.3K sh	—	—	50,337
2021-05-03	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	COO, CFO	MExercise/Conversion	−4,500 sh	—	—	232,534
2021-05-03	PMVPPMV Pharmaceuticals, Inc.S Sale	COO, CFO	SSale	−4,500 sh	$33.75	−$152K	1,600
2021-05-03	PMVPPMV Pharmaceuticals, Inc.M Exercise/Conversion	COO, CFO	MExercise/Conversion	+4,500 sh	$3.22	+$14.5K	6,100
2020-12-08	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	COO, CFO	MExercise/Conversion	−1,600 sh	—	—	237,034
2020-12-08	PMVPPMV Pharmaceuticals, Inc.M Exercise/Conversion	COO, CFO	MExercise/Conversion	+1,600 sh	$3.22	+$5,152	1,600

Recent filings

Accepted (ET)
Jun 124
Kung Winston0001666963-26-000003
SEC(opens sec.gov)
Jun 114
Kung Winston0001193125-26-267672
SEC(opens sec.gov)
May 214
Kung Winston0001193125-26-234860
SEC(opens sec.gov)
Feb 44
Kung Winston0001104659-26-010473
SEC(opens sec.gov)
Jun 134
Kung Winston0001415889-25-017310
SEC(opens sec.gov)
Jun 24
Kung Winston0000950170-25-080313
SEC(opens sec.gov)
Feb 144
Kung Winston0001104659-25-014164
SEC(opens sec.gov)
Aug 204
Kung Winston0000950170-24-099175
SEC(opens sec.gov)
Jun 284
Kung Winston0001415889-24-018441
SEC(opens sec.gov)
Jun 164
Kung Winston0001209191-23-037981
SEC(opens sec.gov)
May 154
Kung Winston0001209191-23-029594
SEC(opens sec.gov)
Jan 304
Kung Winston0001209191-23-005476
SEC(opens sec.gov)
Sep 224
Kung Winston0001209191-22-051047
SEC(opens sec.gov)

Companies

Address

C/O JANUX THERAPEUTICS, INC. 10955 VISTA SORRENTO PARKWAY, SUITE 200

SAN DIEGO, CA, 92130